Related Experiment Videos
New chemotherapeutic agents--bleomycin and adriamycin
CA: a Cancer Journal for Clinicians
|November 1, 1974
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Clinical strategy for the development of angiogenesis inhibitors.
The oncologist·2000
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
The cancer journal from Scientific American·2000
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries.
CA: a cancer journal for clinicians·2026
Serious mental illness and cancer: A call to action for equitable care.
CA: a cancer journal for clinicians·2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable.
CA: a cancer journal for clinicians·2026
Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.
CA: a cancer journal for clinicians·2026
Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.
CA: a cancer journal for clinicians·2026
Haloperidol-Ondansetron versus Dexamethasone-Ondansetron for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Randomized Double-Blind Non-Inferiority Trial.
Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·2026
Monoclonal Antibody-Based Anti-Cryptococcosis Therapy.
Monoclonal antibodies in immunodiagnosis and immunotherapy·2026